Click for best price
Genetic Disorders Drug Market Size, Share 2023
The global Genetic Disorders Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Genetic Disorders Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Disorders Drug. This report contains market size and forecasts of Genetic Disorders Drug in global, including the following market information:
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Cystic Fibrosis (CF) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Genetic Disorders Drug include Sanofi, Vertex, Takeda, Amgen, GW Pharmaceuticals, Pfizer, BioMarin and Sarepta, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Genetic Disorders Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genetic Disorders Drug Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Doses)
Global Genetic Disorders Drug Market Segment Percentages, by Type, 2022 (%)
- Cystic Fibrosis (CF)
- Duchenne Muscular Dystrophy (DMD)
- Lysosomal Storage Disease (LSD)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
Global Genetic Disorders Drug Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Doses)
Global Genetic Disorders Drug Market Segment Percentages, by Application, 2022 (%)
Global Genetic Disorders Drug Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Doses)
Global Genetic Disorders Drug Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Genetic Disorders Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Genetic Disorders Drug revenues share in global market, 2022 (%)
- Key companies Genetic Disorders Drug sales in global market, 2018-2023 (Estimated), (K Doses)
- Key companies Genetic Disorders Drug sales share in global market, 2022 (%)
Key players include:
- Sanofi
- Vertex
- Takeda
- Amgen
- GW Pharmaceuticals
- Pfizer
- BioMarin
- Sarepta
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genetic Disorders Drug, market overview.
Chapter 2: Global Genetic Disorders Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Genetic Disorders Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genetic Disorders Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Genetic Disorders Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Genetic Disorders Drug Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
200 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Genetic Disorders Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genetic Disorders Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genetic Disorders Drug Overall Market Size
2.1 Global Genetic Disorders Drug Market Size: 2022 VS 2032
2.2 Global Genetic Disorders Drug Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Genetic Disorders Drug Sales: 2018-2032
3 Company Landscape
3.1 Top Genetic Disorders Drug Players in Global Market
3.2 Top Global Genetic Disorders Drug Companies Ranked by Revenue
3.3 Global Genetic Disorders Drug Revenue by Companies
3.4 Global Genetic Disorders Drug Sales by Companies
3.5 Global Genetic Disorders Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Genetic Disorders Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Genetic Disorders Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Genetic Disorders Drug Players in Global Market
3.8.1 List of Global Tier 1 Genetic Disorders Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Genetic Disorders Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Genetic Disorders Drug Market Size Markets, 2022 & 2032
4.1.2 Cystic Fibrosis (CF)
4.1.3 Duchenne Muscular Dystrophy (DMD)
4.1.4 Lysosomal Storage Disease (LSD)
4.1.5 Paroxysmal Nocturnal Hemoglobinuria (PNH)
4.2 By Type - Global Genetic Disorders Drug Revenue & Forecasts
4.2.1 By Type - Global Genetic Disorders Drug Revenue, 2018-2023
4.2.2 By Type - Global Genetic Disorders Drug Revenue, 2024-2032
4.2.3 By Type - Global Genetic Disorders Drug Revenue Market Share, 2018-2032
4.3 By Type - Global Genetic Disorders Drug Sales & Forecasts
4.3.1 By Type - Global Genetic Disorders Drug Sales, 2018-2023
4.3.2 By Type - Global Genetic Disorders Drug Sales, 2024-2032
4.3.3 By Type - Global Genetic Disorders Drug Sales Market Share, 2018-2032
4.4 By Type - Global Genetic Disorders Drug Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genetic Disorders Drug Market Size, 2022 & 2032
5.1.2 Clinic
5.1.3 Hospital
5.2 By Application - Global Genetic Disorders Drug Revenue & Forecasts
5.2.1 By Application - Global Genetic Disorders Drug Revenue, 2018-2023
5.2.2 By Application - Global Genetic Disorders Drug Revenue, 2024-2032
5.2.3 By Application - Global Genetic Disorders Drug Revenue Market Share, 2018-2032
5.3 By Application - Global Genetic Disorders Drug Sales & Forecasts
5.3.1 By Application - Global Genetic Disorders Drug Sales, 2018-2023
5.3.2 By Application - Global Genetic Disorders Drug Sales, 2024-2032
5.3.3 By Application - Global Genetic Disorders Drug Sales Market Share, 2018-2032
5.4 By Application - Global Genetic Disorders Drug Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Genetic Disorders Drug Market Size, 2022 & 2032
6.2 By Region - Global Genetic Disorders Drug Revenue & Forecasts
6.2.1 By Region - Global Genetic Disorders Drug Revenue, 2018-2023
6.2.2 By Region - Global Genetic Disorders Drug Revenue, 2024-2032
6.2.3 By Region - Global Genetic Disorders Drug Revenue Market Share, 2018-2032
6.3 By Region - Global Genetic Disorders Drug Sales & Forecasts
6.3.1 By Region - Global Genetic Disorders Drug Sales, 2018-2023
6.3.2 By Region - Global Genetic Disorders Drug Sales, 2024-2032
6.3.3 By Region - Global Genetic Disorders Drug Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Genetic Disorders Drug Revenue, 2018-2032
6.4.2 By Country - North America Genetic Disorders Drug Sales, 2018-2032
6.4.3 US Genetic Disorders Drug Market Size, 2018-2032
6.4.4 Canada Genetic Disorders Drug Market Size, 2018-2032
6.4.5 Mexico Genetic Disorders Drug Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Genetic Disorders Drug Revenue, 2018-2032
6.5.2 By Country - Europe Genetic Disorders Drug Sales, 2018-2032
6.5.3 Germany Genetic Disorders Drug Market Size, 2018-2032
6.5.4 France Genetic Disorders Drug Market Size, 2018-2032
6.5.5 U.K. Genetic Disorders Drug Market Size, 2018-2032
6.5.6 Italy Genetic Disorders Drug Market Size, 2018-2032
6.5.7 Russia Genetic Disorders Drug Market Size, 2018-2032
6.5.8 Nordic Countries Genetic Disorders Drug Market Size, 2018-2032
6.5.9 Benelux Genetic Disorders Drug Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Genetic Disorders Drug Revenue, 2018-2032
6.6.2 By Region - Asia Genetic Disorders Drug Sales, 2018-2032
6.6.3 China Genetic Disorders Drug Market Size, 2018-2032
6.6.4 Japan Genetic Disorders Drug Market Size, 2018-2032
6.6.5 South Korea Genetic Disorders Drug Market Size, 2018-2032
6.6.6 Southeast Asia Genetic Disorders Drug Market Size, 2018-2032
6.6.7 India Genetic Disorders Drug Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Genetic Disorders Drug Revenue, 2018-2032
6.7.2 By Country - South America Genetic Disorders Drug Sales, 2018-2032
6.7.3 Brazil Genetic Disorders Drug Market Size, 2018-2032
6.7.4 Argentina Genetic Disorders Drug Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Genetic Disorders Drug Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Genetic Disorders Drug Sales, 2018-2032
6.8.3 Turkey Genetic Disorders Drug Market Size, 2018-2032
6.8.4 Israel Genetic Disorders Drug Market Size, 2018-2032
6.8.5 Saudi Arabia Genetic Disorders Drug Market Size, 2018-2032
6.8.6 UAE Genetic Disorders Drug Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Genetic Disorders Drug Major Product Offerings
7.1.4 Sanofi Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Vertex
7.2.1 Vertex Company Summary
7.2.2 Vertex Business Overview
7.2.3 Vertex Genetic Disorders Drug Major Product Offerings
7.2.4 Vertex Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.2.5 Vertex Key News & Latest Developments
7.3 Takeda
7.3.1 Takeda Company Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Genetic Disorders Drug Major Product Offerings
7.3.4 Takeda Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.3.5 Takeda Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Genetic Disorders Drug Major Product Offerings
7.4.4 Amgen Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.4.5 Amgen Key News & Latest Developments
7.5 GW Pharmaceuticals
7.5.1 GW Pharmaceuticals Company Summary
7.5.2 GW Pharmaceuticals Business Overview
7.5.3 GW Pharmaceuticals Genetic Disorders Drug Major Product Offerings
7.5.4 GW Pharmaceuticals Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.5.5 GW Pharmaceuticals Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Genetic Disorders Drug Major Product Offerings
7.6.4 Pfizer Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 BioMarin
7.7.1 BioMarin Company Summary
7.7.2 BioMarin Business Overview
7.7.3 BioMarin Genetic Disorders Drug Major Product Offerings
7.7.4 BioMarin Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.7.5 BioMarin Key News & Latest Developments
7.8 Sarepta
7.8.1 Sarepta Company Summary
7.8.2 Sarepta Business Overview
7.8.3 Sarepta Genetic Disorders Drug Major Product Offerings
7.8.4 Sarepta Genetic Disorders Drug Sales and Revenue in Global (2018-2023)
7.8.5 Sarepta Key News & Latest Developments
8 Global Genetic Disorders Drug Production Capacity, Analysis
8.1 Global Genetic Disorders Drug Production Capacity, 2018-2032
8.2 Genetic Disorders Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Genetic Disorders Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Genetic Disorders Drug Supply Chain Analysis
10.1 Genetic Disorders Drug Industry Value Chain
10.2 Genetic Disorders Drug Upstream Market
10.3 Genetic Disorders Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Genetic Disorders Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Genetic Disorders Drug in Global Market
Table 2. Top Genetic Disorders Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Genetic Disorders Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Genetic Disorders Drug Revenue Share by Companies, 2018-2023
Table 5. Global Genetic Disorders Drug Sales by Companies, (K Doses), 2018-2023
Table 6. Global Genetic Disorders Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Genetic Disorders Drug Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Genetic Disorders Drug Product Type
Table 9. List of Global Tier 1 Genetic Disorders Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genetic Disorders Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Genetic Disorders Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Genetic Disorders Drug Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Genetic Disorders Drug Sales (K Doses), 2018-2023
Table 15. By Type - Global Genetic Disorders Drug Sales (K Doses), 2024-2032
Table 16. By Application ? Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Genetic Disorders Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Genetic Disorders Drug Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Genetic Disorders Drug Sales (K Doses), 2018-2023
Table 20. By Application - Global Genetic Disorders Drug Sales (K Doses), 2024-2032
Table 21. By Region ? Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Genetic Disorders Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Genetic Disorders Drug Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Genetic Disorders Drug Sales (K Doses), 2018-2023
Table 25. By Region - Global Genetic Disorders Drug Sales (K Doses), 2024-2032
Table 26. By Country - North America Genetic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Genetic Disorders Drug Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Genetic Disorders Drug Sales, (K Doses), 2018-2023
Table 29. By Country - North America Genetic Disorders Drug Sales, (K Doses), 2024-2032
Table 30. By Country - Europe Genetic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Genetic Disorders Drug Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Genetic Disorders Drug Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Genetic Disorders Drug Sales, (K Doses), 2024-2032
Table 34. By Region - Asia Genetic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Genetic Disorders Drug Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Genetic Disorders Drug Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Genetic Disorders Drug Sales, (K Doses), 2024-2032
Table 38. By Country - South America Genetic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Genetic Disorders Drug Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Genetic Disorders Drug Sales, (K Doses), 2018-2023
Table 41. By Country - South America Genetic Disorders Drug Sales, (K Doses), 2024-2032
Table 42. By Country - Middle East & Africa Genetic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Genetic Disorders Drug Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Genetic Disorders Drug Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Genetic Disorders Drug Sales, (K Doses), 2024-2032
Table 46. Sanofi Company Summary
Table 47. Sanofi Genetic Disorders Drug Product Offerings
Table 48. Sanofi Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Vertex Company Summary
Table 51. Vertex Genetic Disorders Drug Product Offerings
Table 52. Vertex Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Vertex Key News & Latest Developments
Table 54. Takeda Company Summary
Table 55. Takeda Genetic Disorders Drug Product Offerings
Table 56. Takeda Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Takeda Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Genetic Disorders Drug Product Offerings
Table 60. Amgen Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Amgen Key News & Latest Developments
Table 62. GW Pharmaceuticals Company Summary
Table 63. GW Pharmaceuticals Genetic Disorders Drug Product Offerings
Table 64. GW Pharmaceuticals Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. GW Pharmaceuticals Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Genetic Disorders Drug Product Offerings
Table 68. Pfizer Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. BioMarin Company Summary
Table 71. BioMarin Genetic Disorders Drug Product Offerings
Table 72. BioMarin Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. BioMarin Key News & Latest Developments
Table 74. Sarepta Company Summary
Table 75. Sarepta Genetic Disorders Drug Product Offerings
Table 76. Sarepta Genetic Disorders Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Sarepta Key News & Latest Developments
Table 78. Genetic Disorders Drug Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 79. Global Genetic Disorders Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Genetic Disorders Drug Production by Region, 2018-2023 (K Doses)
Table 81. Global Genetic Disorders Drug Production by Region, 2024-2032 (K Doses)
Table 82. Genetic Disorders Drug Market Opportunities & Trends in Global Market
Table 83. Genetic Disorders Drug Market Drivers in Global Market
Table 84. Genetic Disorders Drug Market Restraints in Global Market
Table 85. Genetic Disorders Drug Raw Materials
Table 86. Genetic Disorders Drug Raw Materials Suppliers in Global Market
Table 87. Typical Genetic Disorders Drug Downstream
Table 88. Genetic Disorders Drug Downstream Clients in Global Market
Table 89. Genetic Disorders Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Genetic Disorders Drug Segment by Type in 2022
Figure 2. Genetic Disorders Drug Segment by Application in 2022
Figure 3. Global Genetic Disorders Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genetic Disorders Drug Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Genetic Disorders Drug Revenue, 2018-2032 (US$, Mn)
Figure 7. Genetic Disorders Drug Sales in Global Market: 2018-2032 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Genetic Disorders Drug Revenue in 2022
Figure 9. By Type - Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Genetic Disorders Drug Revenue Market Share, 2018-2032
Figure 11. By Type - Global Genetic Disorders Drug Sales Market Share, 2018-2032
Figure 12. By Type - Global Genetic Disorders Drug Price (USD/Dose), 2018-2032
Figure 13. By Application - Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Genetic Disorders Drug Revenue Market Share, 2018-2032
Figure 15. By Application - Global Genetic Disorders Drug Sales Market Share, 2018-2032
Figure 16. By Application - Global Genetic Disorders Drug Price (USD/Dose), 2018-2032
Figure 17. By Region - Global Genetic Disorders Drug Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Genetic Disorders Drug Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Genetic Disorders Drug Revenue Market Share, 2018-2032
Figure 20. By Region - Global Genetic Disorders Drug Sales Market Share, 2018-2032
Figure 21. By Country - North America Genetic Disorders Drug Revenue Market Share, 2018-2032
Figure 22. By Country - North America Genetic Disorders Drug Sales Market Share, 2018-2032
Figure 23. US Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Genetic Disorders Drug Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Genetic Disorders Drug Sales Market Share, 2018-2032
Figure 28. Germany Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 29. France Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Genetic Disorders Drug Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Genetic Disorders Drug Sales Market Share, 2018-2032
Figure 37. China Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 41. India Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Genetic Disorders Drug Revenue Market Share, 2018-2032
Figure 43. By Country - South America Genetic Disorders Drug Sales Market Share, 2018-2032
Figure 44. Brazil Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Genetic Disorders Drug Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Genetic Disorders Drug Sales Market Share, 2018-2032
Figure 48. Turkey Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Genetic Disorders Drug Revenue, (US$, Mn), 2018-2032
Figure 52. Global Genetic Disorders Drug Production Capacity (K Doses), 2018-2032
Figure 53. The Percentage of Production Genetic Disorders Drug by Region, 2022 VS 2032
Figure 54. Genetic Disorders Drug Industry Value Chain
Figure 55. Marketing Channels
